Table 2.
Characteristics | DPP N (%) or median (IQR) (N = 39) | DCD with NRP N (%) or median (IQR) (N = 25) | Total DCD lung N (%) or median (IQR) (N = 64) | P value |
---|---|---|---|---|
Donor age (y) | 30.0 (23.0-35.0) | 21.0 (18.0-34.0) | 27.0 (21.0-35.0) | .051∗ |
Calculated donor BMI | 25.9 (22.9-29.2) | 24.1 (21.3-26.6) | 25.0 (22.0-27.7) | .103∗ |
Male donor | 31 (79.5%) | 25 (100.0%) | 56 (87.5%) | .018† |
Year organ was recovered | .011† | |||
2019 | 3 (7.7%) | 0 (0.0%) | 3 (4.7%) | |
2020 | 14 (35.9%) | 3 (12.0%) | 17 (26.6%) | |
2021 | 21 (53.8%) | 17 (68.0%) | 38 (59.4%) | |
2022 | 1 (2.6%) | 5 (20.0%) | 6 (9.4%) | |
Cause of death | .441† | |||
Anoxia | 10 (25.6%) | 10 (40.0%) | 20 (31.3%) | |
Cerebrovascular | 3 (7.7%) | 3 (12.0%) | 6 (9.4%) | |
Head trauma | 25 (64.1%) | 12 (48.0%) | 37 (57.8%) | |
History of smoking | 1 (2.6%) | 1 (4.0%) | 2 (3.2%) | .999† |
History of diabetes | 2 (5.1%) | 0 (0.0%) | 2 (3.1%) | .516† |
History of hypertension | 4 (10.3%) | 3 (12.0%) | 7 (10.9%) | .999† |
Standstill to clamp (min) | 8.0 (8.0-10.0) | 72.0 (67.0-118.0) | 10.5 (8.0-68.0) | - |
PaO2 on 100% FiO2 | 417.0 (318.0-473.0) | 400.0 (218.0-455.0) | 412 (316.5-459.0) | .554∗ |
Heart transplanted | 34 (87.2%) | 24 (96.0%) | 58 (90.6%) | .391† |
Lungs recovered | 74 | 47 | 121 | .999† |
Single | 4 (10.3%) | 3 (12.0%) | 7 (10.9%) | |
Bilateral | 35 (89.7%) | 22 (88.0%) | 57 (89.1%) | |
Lungs discarded | 23 (31.1%) | 16 (34.0%) | 39 (32.2%) | .999† |
Single | 3 | 2 | 5 | |
Bilateral | 10 | 7 | 17 | |
Lungs transplanted | 51 (68.9%) | 31 (66.0%) | 82 (67.8%) | .384† |
Single | 3 | 5 | 8 | |
Bilateral | 24 | 13 | 37 |
DPP, Direct procurement followed by perfusion; IQR, interquartile range; DCD, donation after circulatory death; NRP, normothermic regional perfusion; BMI, body mass index.
Wilcoxon.
Fisher exact.